Helicobacter pylori-induced inflammation masks the underlying presence of low-grade dysplasia on gastric lesions

Alba Panarese, Giovanni Galatola, Raffaele Armentano, Pedro Pimentel-Nunes, Enzo Ierardi, Maria Lucia Caruso, Francesco Pesce, Marco Vincenzo Lenti, Valeria Palmitessa, Sergio Coletta, Endrit Shahini

Research output: Contribution to journalArticle

Abstract

BACKGROUND: Helicobacter pylori (H. pylori) infection has been associated with a long-term risk of precancerous gastric conditions (PGC) even after H. pylori eradication. AIM: To investigate the efficacy of High-Resolution White-Light Endoscopy with Narrow-Band Imaging in detecting PGC, before/after H. pylori eradication. METHODS: We studied 85 consecutive patients with H. pylori-related gastritis with/without PGC before and 6 mo after proven H. pylori eradication. Kimura-Takemoto modified and endoscopic grading of gastric intestinal metaplasia classifications, were applied to assess the endoscopic extension of atrophy and intestinal metaplasia. The histological result was considered to be the gold standard. The Sydney System, the Operative-Link on Gastritis-Assessment, and the Operative-Link on Gastric-Intestinal Metaplasia were used for defining histological gastritis, atrophy and intestinal metaplasia, whereas dysplasia was graded according to World Health Organization classification. Serum anti-parietal cell antibody and anti-intrinsic factor were measured when autoimmune atrophic gastritis was suspected. RESULTS: After H. pylori eradication histological signs of mononuclear/polymorphonuclear cell infiltration and Mucosal Associated Lymphoid Tissue-hyperplasia, disappeared or decreased in 100% and 96.5% of patients respectively, whereas the Operative-Link on Gastritis-Assessment and Operative-Link on Gastric-Intestinal Metaplasia stages did not change. Low-Grade Dysplasia prevalence was similar on random biopsies before and after H. pylori eradication (17.6% vs 10.6%, P = 0.19), but increased in patients with visible lesions (0% vs 22.4%, P < 0.0001). At a multivariate analysis, the probability for detecting dysplasia after resolution of H. pylori-related active inflammation was higher in patients with regression or reduction of Mucosal Associated Lymphoid Tissue hyperplasia, greater alcohol consumption, and anti-parietal cell antibody and/or anti-intrinsic factor positivity [odds ratio (OR) = 3.88, 95% confidence interval (CI): 1.31-11.49, P = 0.01; OR = 3.10, 95%CI: 1.05-9.12, P = 0.04 and OR = 5.47, 95%CI: 1.33-22.39, P < 0.04, respectively]. CONCLUSION: High-Resolution White-Light Endoscopy with Narrow-Band Imaging allows an accurate diagnosis of Low-Grade Dysplasia on visible lesions after regression of H. pylori-induced chronic gastritis. Patients with an overlap between autoimmune/H. pylori-induced gastritis may require more extensive gastric mapping.

Original languageEnglish
Pages (from-to)3834-3850
Number of pages17
JournalWorld Journal of Gastroenterology
Volume26
Issue number26
DOIs
Publication statusPublished - Jul 14 2020

Keywords

  • Autoimmune gastritis
  • Diagnosis
  • Dysplasia
  • Gastric cancer
  • Malignancy
  • Signs
  • Symptoms

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint Dive into the research topics of 'Helicobacter pylori-induced inflammation masks the underlying presence of low-grade dysplasia on gastric lesions'. Together they form a unique fingerprint.

  • Cite this